Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results.
Siddiq, Somiah Stephen, Sarah Lin, Daniel Fox, Hannah Robinson, Max Paleri, Vinidh
Siddiq, Somiah
Stephen, Sarah
Lin, Daniel
Fox, Hannah
Robinson, Max
Paleri, Vinidh
Abstract
Introduction: To report the long-term oncological and functional outcomes of en bloc TORS lateral oropharyngectomy to address the close/involved margin following diagnostic tonsillectomy in HPV-related SCC of unknown primary.
Material and methods: A single tertiary center observational cohort over a 4-year period. Primary outcome measures were disease-specific survival (DSS), overall survival (OS), and PSS NOD (Performance Status Scale-Normalcy of Diet) scores.
Results: TORS specimens did not evidence residual carcinoma in 93% of patients. Of 14 patients, 50% received surgery alone (median follow-up 57 months; range 46-96), the remainder surgery and adjuvant therapy (median follow-up of 58 months; range 51-69) with 100% DSS, OS and no deterioration of PSS NOD scores.
Conclusions: Long-term oncological outcomes confirm TORS lateral oropharyngectomy alone is an oncologically safe treatment. Due consideration of this approach is warranted to mitigate against the morbidity of adjuvant radiotherapy treatment in this group of patients.
MIDER Authors
Affiliations
Citations
Altmetric:
Date
2022-09-03
Type
Article
Subject
Collections
Citation
Siddiq S, Stephen S, Lin D, Fox H, Robinson M, Paleri V. Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results. Head Neck. 2022 Dec;44(12):2753-2759. doi: 10.1002/hed.27186. Epub 2022 Sep 3